GSK233705

CAS No. 850607-58-8

GSK233705( —— )

Catalog No. M34566 CAS No. 850607-58-8

GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 198 Get Quote
5MG 304 Get Quote
10MG 456 Get Quote
25MG 723 Get Quote
50MG 994 Get Quote
100MG 1332 Get Quote
500MG 2664 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK233705
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.
  • Description
    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    850607-58-8
  • Formula Weight
    425.4
  • Molecular Formula
    C24H29BrN2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C[C@@H]1C[C@]2([N+](C)(C)[C@@](C1)(CC2)[H])[H])(C#N)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Posatirelin

    Posatirelin (BRN6006446) is a synthetic peptide with modulatory activity and neurotrophic effects on monoaminergic and cholinergic systems for the study of vascular dementia.

  • LY2033298

    LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.

  • Velufenacin

    Velufenacin is an antagonist of muscarinic receptor.